person · Reporting owner
Hidalgo Medina Manuel
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BRISTOL MYERS SQUIBB COBMY · Entity 1662 | Director | February 01, 2026 | February 03, 2026 |
| Guardant Health, Inc.GH · Entity 3238 | Director | September 17, 2026 | September 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BRISTOL MYERS SQUIBB CO
Report date February 01, 2026 · Filed February 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Share UnitsSEC Table II · derivative / convertible security | Direct | 22,763.938 |
Reported balance
After 2026-02-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-02-01 · Grant · Acquired 3,996.367 · Balance 22,763.938 F1: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.
F2: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.
Guardant Health, Inc.
Report date September 17, 2026 · Filed September 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,020 |
Reported balance
After 2026-09-17 transaction · row 1
1 source rowRow 1 · 2026-09-17 · Exercise / conversion · Acquired 232 · Balance 5,020 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 5,105 |
Reported balance
After 2026-09-17 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-17 · Exercise / conversion · Disposed 232 · Balance 5,105 F1: The restricted stock unit award granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award vested on July 17, 2025 and the remaining 75% vests monthly for the three-year period thereafter. F2: Not applicable for Restricted Stock Units. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock unit award granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award vested on July 17, 2025 and the remaining 75% vests monthly for the three-year period thereafter.
F2: Not applicable for Restricted Stock Units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 17, 2026 Filed Sep 21, 2026 22:16 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 232 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001865525-26-000028 · wk-form4_1790028995.xml · derivative · entry 2 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,105 Underlying: Common Stock · 232 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit award granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award vested on July 17, 2025 and the remaining 75% vests monthly for the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| September 17, 2026 Filed Sep 21, 2026 22:16 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 232 | $0.00 | $0.00 |
DisclosureSEC source: 0001865525-26-000028 · wk-form4_1790028995.xml · nonDerivative · entry 1 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,020 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2026 Filed Aug 18, 2026 22:16 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 232 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001865525-26-000026 · wk-form4_1787091359.xml · derivative · entry 2 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,337 Underlying: Common Stock · 232 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit award granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award vested on July 17, 2025 and the remaining 75% vests monthly for the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| August 17, 2026 Filed Aug 18, 2026 22:16 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 232 | $0.00 | $0.00 |
DisclosureSEC source: 0001865525-26-000026 · wk-form4_1787091359.xml · nonDerivative · entry 1 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,788 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 05, 2026 Filed Aug 6, 2026 21:06 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionStock Option (Right to Buy) · Derivative | 950 | $0.00 Strike: $32.55 | $0.00 |
DisclosureSEC source: 0001865525-26-000024 · wk-form4_1786050361.xml · derivative · entry 4 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,079 Underlying: Common Stock · 950 shares Expires 2034-07-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award vested on July 17, 2025 and the remaining 75% vests monthly for the three-year period thereafter. Read SEC document |
| August 05, 2026 Filed Aug 6, 2026 21:06 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 750 | $164.61 | $123,453.83 |
DisclosureSEC source: 0001865525-26-000024 · wk-form4_1786050361.xml · nonDerivative · entry 3 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,556 Read SEC document |
| August 05, 2026 Filed Aug 6, 2026 21:06 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 950 | $163.95 | $155,747.75 |
DisclosureSEC source: 0001865525-26-000024 · wk-form4_1786050361.xml · nonDerivative · entry 2 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,306 Read SEC document |
| August 05, 2026 Filed Aug 6, 2026 21:06 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 950 | $32.55 | $30,922.50 |
DisclosureSEC source: 0001865525-26-000024 · wk-form4_1786050361.xml · nonDerivative · entry 1 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,256 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 17, 2026 Filed Jul 20, 2026 21:07 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 232 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001865525-26-000022 · wk-form4_1784581620.xml · derivative · entry 2 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,569 Underlying: Common Stock · 232 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit award granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award vested on July 17, 2025 and the remaining 75% vests monthly for the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| July 17, 2026 Filed Jul 20, 2026 21:07 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 232 | $0.00 | $0.00 |
DisclosureSEC source: 0001865525-26-000022 · wk-form4_1784581620.xml · nonDerivative · entry 1 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,306 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 21:52 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRestricted Stock Units · Derivative | 2,711 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001865525-26-000020 · wk-form4_1782165138.xml · derivative · entry 5 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,711 Underlying: Common Stock · 2,711 shares Expires not disclosed F4 · derivative.exercise_date: The restricted stock unit award vests in full on the one-year anniversary of the grant date, June 17, 2026, or the date of the Company's next annual meeting of stockholders, whichever is earlier. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 21:52 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 4,203 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001865525-26-000020 · wk-form4_1782165138.xml · derivative · entry 4 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,203 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The restricted stock unit award vested in full on the date of the 2026 Annual Meeting of Stockholders which was held on June 17, 2026. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 21:52 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 232 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001865525-26-000020 · wk-form4_1782165138.xml · derivative · entry 3 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,801 Underlying: Common Stock · 232 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit award granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award vested on July 17, 2025 and the remaining 75% vests monthly for the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 21:52 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 4,203 | $0.00 | $0.00 |
DisclosureSEC source: 0001865525-26-000020 · wk-form4_1782165138.xml · nonDerivative · entry 2 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,074 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 21:52 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 232 | $0.00 | $0.00 |
DisclosureSEC source: 0001865525-26-000020 · wk-form4_1782165138.xml · nonDerivative · entry 1 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 871 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 28, 2026 Filed May 29, 2026 21:30 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 1,000 | $130.06 | $130,060.10 |
DisclosureSEC source: 0001865525-26-000018 · wk-form4_1780090235.xml · nonDerivative · entry 1 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 639 Read SEC document |
| May 20, 2026 Filed May 22, 2026 20:56 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $32.55 | $0.00 |
DisclosureSEC source: 0001865525-26-000016 · wk-form4_1779483405.xml · derivative · entry 4 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,029 Underlying: Common Stock · 1,000 shares Expires 2034-07-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option award that was granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award vested July 17, 2025 and the remaining 75% vests monthly for the three-year period thereafter. Read SEC document |
| May 20, 2026 Filed May 22, 2026 20:56 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 250 | $107.07 | $26,768.25 |
DisclosureSEC source: 0001865525-26-000016 · wk-form4_1779483405.xml · nonDerivative · entry 3 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,639 Read SEC document |
| May 20, 2026 Filed May 22, 2026 20:56 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 1,000 | $107.10 | $107,095.60 |
DisclosureSEC source: 0001865525-26-000016 · wk-form4_1779483405.xml · nonDerivative · entry 2 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,889 F1 · price: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $107.00 to $107.32. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 20, 2026 Filed May 22, 2026 20:56 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,000 | $32.55 | $32,550.00 |
DisclosureSEC source: 0001865525-26-000016 · wk-form4_1779483405.xml · nonDerivative · entry 1 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,889 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 17, 2026 Filed May 19, 2026 22:01 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 232 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001865525-26-000014 · wk-form4_1779228107.xml · derivative · entry 2 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,033 Underlying: Common Stock · 232 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award vested on July 17, 2025 and the remaining 75% vests monthly for the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| May 17, 2026 Filed May 19, 2026 22:01 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 232 | $0.00 | $0.00 |
DisclosureSEC source: 0001865525-26-000014 · wk-form4_1779228107.xml · nonDerivative · entry 1 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,889 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 17, 2026 Filed Apr 20, 2026 22:20 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 232 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001865525-26-000012 · wk-form4_1776723645.xml · derivative · entry 2 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,265 Underlying: Common Stock · 232 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit award granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award vested on July 17, 2025 and the remaining 75% vests monthly for the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| April 17, 2026 Filed Apr 20, 2026 22:20 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 232 | $0.00 | $0.00 |
DisclosureSEC source: 0001865525-26-000012 · wk-form4_1776723645.xml · nonDerivative · entry 1 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,657 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 17, 2026 Filed Mar 18, 2026 21:40 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 232 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001865525-26-000010 · wk-form4_1773870001.xml · derivative · entry 2 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,497 Underlying: Common Stock · 232 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit award granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of July 17, 2024 and the remaining 75% vests monthly for the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| March 17, 2026 Filed Mar 18, 2026 21:40 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 232 | $0.00 | $0.00 |
DisclosureSEC source: 0001865525-26-000010 · wk-form4_1773870001.xml · nonDerivative · entry 1 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,425 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2026 Filed Mar 9, 2026 22:38 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $32.55 | $0.00 |
DisclosureSEC source: 0001865525-26-000008 · wk-form4_1773095892.xml · derivative · entry 4 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,029 Underlying: Common Stock · 1,000 shares Expires 2034-07-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This represents a stock option award granted on July 17, 2024 and vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of July 17, 2024 and the remaining 75% vests monthly for the three-year period thereafter. Read SEC document |
| March 06, 2026 Filed Mar 9, 2026 22:38 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 300 | $91.30 | $27,390.03 |
DisclosureSEC source: 0001865525-26-000008 · wk-form4_1773095892.xml · nonDerivative · entry 3 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,193 Read SEC document |
| March 06, 2026 Filed Mar 9, 2026 22:38 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 1,000 | $91.61 | $91,606.50 |
DisclosureSEC source: 0001865525-26-000008 · wk-form4_1773095892.xml · nonDerivative · entry 2 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,493 Read SEC document |
| March 06, 2026 Filed Mar 9, 2026 22:38 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,000 | $32.55 | $32,550.00 |
DisclosureSEC source: 0001865525-26-000008 · wk-form4_1773095892.xml · nonDerivative · entry 1 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,493 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2026 Filed Feb 18, 2026 21:27 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 232 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001865525-26-000006 · wk-form4_1771450066.xml · derivative · entry 2 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,729 Underlying: Common Stock · 232 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit award granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of July 17, 2024 and the remaining 75% vests monthly for the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| February 17, 2026 Filed Feb 18, 2026 21:27 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 232 | $0.00 | $0.00 |
DisclosureSEC source: 0001865525-26-000006 · wk-form4_1771450066.xml · nonDerivative · entry 1 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,493 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:25 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 3,996.367 | $55.05 | $220,000.00 |
DisclosureSEC source: 0001865525-26-000004 · wk-form4_1770153932.xml · derivative · entry 1 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,763.938 Underlying: Common Stock, $0.10 par value · 3,996.367 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| January 17, 2026 Filed Jan 20, 2026 21:47 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 232 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001865525-26-000002 · wk-form4_1768945676.xml · derivative · entry 2 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,961 Underlying: Common Stock · 232 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit award granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of July 17, 2024 and the remaining 75% vests monthly for the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| January 17, 2026 Filed Jan 20, 2026 21:47 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 232 | $0.00 | $0.00 |
DisclosureSEC source: 0001865525-26-000002 · wk-form4_1768945676.xml · nonDerivative · entry 1 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,261 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 17, 2025 Filed Dec 18, 2025 23:34 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 232 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001865525-25-000017 · wk-form4_1766100850.xml · derivative · entry 2 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,193 Underlying: Common Stock · 232 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of July 17, 2024 and the remaining 75% vests monthly for the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| December 17, 2025 Filed Dec 18, 2025 23:34 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 232 | $0.00 | $0.00 |
DisclosureSEC source: 0001865525-25-000017 · wk-form4_1766100850.xml · nonDerivative · entry 1 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,029 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 02:32 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $32.55 | $0.00 |
DisclosureSEC source: 0001865525-25-000015 · wk-form4_1765420331.xml · derivative · entry 4 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,029 Underlying: Common Stock · 1,000 shares Expires 2034-07-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of July 17, 2024. The remaining 75% vests monthly for the three-year period thereafter. Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 02:32 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 250 | $105.00 | $26,250.00 |
DisclosureSEC source: 0001865525-25-000015 · wk-form4_1765420331.xml · nonDerivative · entry 3 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 797 Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 02:32 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 1,000 | $105.00 | $105,000.00 |
DisclosureSEC source: 0001865525-25-000015 · wk-form4_1765420331.xml · nonDerivative · entry 2 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,047 Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 02:32 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,000 | $32.55 | $32,550.00 |
DisclosureSEC source: 0001865525-25-000015 · wk-form4_1765420331.xml · nonDerivative · entry 1 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,047 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 17, 2025 Filed Nov 18, 2025 22:07 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 232 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001865525-25-000013 · wk-form4_1763503670.xml · derivative · entry 2 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,425 Underlying: Common Stock · 232 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit award granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of July 17, 2024 and the remaining 75% vests monthly for the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| November 17, 2025 Filed Nov 18, 2025 22:07 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 232 | $0.00 | $0.00 |
DisclosureSEC source: 0001865525-25-000013 · wk-form4_1763503670.xml · nonDerivative · entry 1 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,047 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2025 Filed Nov 11, 2025 00:18 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $32.55 | $0.00 |
DisclosureSEC source: 0001865525-25-000011 · wk-form4_1762820291.xml · derivative · entry 4 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,029 Underlying: Common Stock · 1,000 shares Expires 2034-07-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of July 17, 2024, and the remaining 75% vests monthly for the three-year period thereafter. Read SEC document |
| November 07, 2025 Filed Nov 11, 2025 00:18 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 500 | $95.23 | $47,615.05 |
DisclosureSEC source: 0001865525-25-000011 · wk-form4_1762820291.xml · nonDerivative · entry 3 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 815 Read SEC document |
| November 07, 2025 Filed Nov 11, 2025 00:18 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 1,000 | $95.17 | $95,165.10 |
DisclosureSEC source: 0001865525-25-000011 · wk-form4_1762820291.xml · nonDerivative · entry 2 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,315 Read SEC document |
| November 07, 2025 Filed Nov 11, 2025 00:18 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,000 | $32.55 | $32,550.00 |
DisclosureSEC source: 0001865525-25-000011 · wk-form4_1762820291.xml · nonDerivative · entry 1 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,315 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 17, 2025 Filed Oct 20, 2025 23:50 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 232 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001865525-25-000009 · wk-form4_1761004237.xml · derivative · entry 2 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,657 Underlying: Common Stock · 232 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of July 17, 2024. The remaining 75% vests monthly for the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| October 17, 2025 Filed Oct 20, 2025 23:50 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 232 | $0.00 | $0.00 |
DisclosureSEC source: 0001865525-25-000009 · wk-form4_1761004237.xml · nonDerivative · entry 1 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,315 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 17, 2025 Filed Sep 18, 2025 20:33 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 232 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001865525-25-000006 · wk-form4_1758227632.xml · derivative · entry 2 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,889 Underlying: Common Stock · 232 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit award granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of July 17, 2024. The remaining 75% vests monthly during the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.